Page 14 - Nasdaq Tech News Today

Bio-Techne (NASDAQ:TECH – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Friday, Zacks.com reports. The firm currently has a $408.00 price target on the biotechnology company’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 14.79% from […]

Bio-Techne Co. (NASDAQ:TECH – Get Rating) CEO Charles R. Kummeth sold 5,104 shares of the company’s stock in a transaction on Tuesday, June 7th. The stock was sold at an average price of $365.00, for a total transaction of $1,862,960.00. Following the transaction, the chief executive officer now directly owns 198,338 shares in the company, […]

Shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) have been assigned an average recommendation of “Buy” from the eight ratings firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have assigned a buy recommendation to the company. […]

Bio-Techne (NASDAQ:TECH – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It […]

Several analysts have recently updated their ratings and price targets for Bio-Techne (NASDAQ: TECH): 5/12/2022 – Bio-Techne was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $394.00 price target on the stock. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It […]

Zacks Investment Research downgraded shares of Bio-Techne (NASDAQ:TECH – Get Rating) from a buy rating to a hold rating in a research report released on Wednesday, Zacks.com reports. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as […]

Bio-Techne (NASDAQ:TECH – Get Rating) was downgraded by stock analysts at Wells Fargo & Company from an “equal weight” rating to an “underweight” rating in a report issued on Monday, The Fly reports. They currently have a $370.00 price objective on the biotechnology company’s stock, down from their previous price objective of $400.00. Wells Fargo […]

Zacks Investment Research upgraded shares of Bio-Techne (NASDAQ:TECH – Get Rating) from a hold rating to a buy rating in a report published on Wednesday, Zacks.com reports. Zacks Investment Research currently has $484.00 price objective on the biotechnology company’s stock. According to Zacks, “Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and […]

StockNews.com started coverage on shares of Bio-Techne (NASDAQ:TECH – Get Rating) in a research report released on Thursday. The firm issued a buy rating on the biotechnology company’s stock. A number of other brokerages have also commented on TECH. Zacks Investment Research upgraded shares of Bio-Techne from a sell rating to a hold rating in […]

Retirement Systems of Alabama decreased its position in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 2.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 13,020 shares of the biotechnology company’s stock after selling 336 shares during the period. Retirement Systems of Alabama’s holdings in Bio-Techne were worth $6,736,000 as of its most recent SEC […]